Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs: 1 blog

twitter: 3 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 13 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 23,804 followers.

Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models https://t.co/uHR0MCD1nB https://t.co/PnWpqJQ9Rt

08 Nov 2022

Reply Repost Favourite

RT @FrontOncology: New research: Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune mo…

08 Nov 2022

Reply Repost Favourite

New research: Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models: Immune checkpoint inhibitors have been found to be effective in metastatic… https://t.co/a

07 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.